Lipid transmitter signaling as a new target for treatment of cocaine addiction: new roles for acylethanolamides and lysophosphatidic acid.

Current pharmaceutical design

Volumn 19, Issue 40, 2013, Pages 7036-7049

  Orio, Laura ^a   Pavón, Francisco Javier ^b   Blanco, Eduardo ^b   Serrano, Antonia ^b   Araos, Pedro ^b   Pedraz, María ^b   Rivera, Patricia ^b   Calado, Montserrat ^b   Suárez, Juan ^b   de Fonseca, Fernando Rodríguez ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; LIPID; LYSOPHOSPHOLIPID; PHOSPHOLIPID;

ANIMAL; BRAIN; COCAINE DEPENDENCE; DRUG DESIGN; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; COCAINE-RELATED DISORDERS; DRUG DESIGN; EICOSANOIDS; HUMANS; LIPIDS; LYSOPHOSPHOLIPIDS; MOLECULAR TARGETED THERAPY; PHOSPHOLIPIDS; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84906801661     PISSN: None     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161281940131209143421     Document Type: Review

References (0)